Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Elise Sverre
Cost-effectiveness of in-hospital motivational smoking cessation counselling and proactive referral to community-based follow-up
INTRODUCTION Tobacco smoking is a major modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD), contributing substantially to the global burden of disease [1, 2]. In 2019, it accounted for approximately 200 million disability-adjusted life-years globally, reflecting its profound health and economic impact [2].
Motivational smoking cessation counselling and community‐based follow‐up after hospitalisation for vascular disease: A randomised controlled trial
INTRODUCTION Approximately one-third of all patients hospitalised for atherosclerotic cardiovascular, cerebrovascular and peripheral artery disease in Europe report daily cigarette smoking [1-3]. Quitting smoking reduces both immediate and long-term risks of recurrent vascular events [4]. Nevertheless, over half of patients with cardiovascular disease resume smoking within 6 months of hospital discharge [5], and more than 70% of patients with peripheral artery disease relapse within a year [6].
Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?
The treatment recommendations for low-density lipoprotein cholesterol (LDL-C) have been intensified in the 2019 European guidelines for the management of dyslipidemias.1 In very high-risk patients, including those with established cardiovascular disease (CVD), a LDL-C reduction of ≥50% from baseline and a LDL-C goal of <1.4 mmol/L received a class 1A recommendation.1 The guidelines recommend starting proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with an acute...
Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients
Understanding the determinants of low-density lipoprotein cholesterol (LDL-C) control constitutes the basis of modelling interventions for optimal lipid control and prognosis. We aim to identify medical and psychosocial (study) factors associated with unfavourable LDL-C control in coronary patients.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Elise
Contact Elise, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack